J. Wendler

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study

Judith Haschka, Matthias Englbrecht, Axel J. Hueber et al. · Annals of the Rheumatic Diseases · 2015 · 202 citations

Medicine, Pharmacotherapy, Disease Prevention +15

Open‐label study of infliximab treatment for psoriatic arthritis: Clinical and magnetic resonance imaging measurements of reduction of inflammation

Christian Antoni, Claudia Dechant, Patrick Lorenz et al. · Arthritis Care & Research · 2002 · 177 citations

Medicine, Immunology, Pharmacotherapy +17

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment

Jürgen Rech, Axel J. Hueber, Stephanie Finzel et al. · Annals of the Rheumatic Diseases · 2015 · 95 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs

Camille P. Figueiredo, Holger Bang, Jayme Fogagnolo Cobra et al. · Annals of the Rheumatic Diseases · 2016 · 63 citations

Life Sciences, Immunology, Internal Medicine +17

Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients

J. Wendler, Gerd R Burmester, H. Sörensen et al. · Arthritis Research & Therapy · 2014 · 59 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15